Diane E. Nedberge
17Patents
14h-index
16Co-inventors
71Inventor score
Filing activity: Oct 9, 1984 → Apr 26, 1999
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4568343A | Skin permeation enhancer compositions | Human Necessities | 270 | Expired |
| US4788062A | Transdermal administration of progesterone, estradiol esters, and mixtures thereof | Human Necessities | 182 | Expired |
| US4746515A | Skin permeation enhancer compositions using glycerol monolaurate | Human Necessities | 131 | Expired |
| US4816258A | Transdermal contraceptive formulations | Emerging Cross-Sectional Technologies | 122 | Expired |
| US5314694A | Transdermal formulations, methods and devices | Human Necessities | 74 | Expired |
| US5641504A | Skin permeation enhancer compositions using glycerol monolinoleate | Human Necessities | 65 | Expired |
| US5411740A | Transdermal administration of oxybutynin | Human Necessities | 62 | Expired |
| US5122382A | Transdermal contraceptive formulations, methods and devices | Human Necessities | 56 | Expired |
| US6007837A | Drug delivery devices and process of manufacture | Human Necessities | 51 | Expired |
| US5376377A | Transdermal contraceptive formulations, methods and devices | Human Necessities | 44 | Expired |
| US5500222A | Transdermal administration of oxybutynin | Human Necessities | 28 | Expired |
| US5919478A | Incorporating poly-N-vinyl amide in a transdermal system | Human Necessities | 27 | Expired |
| US5198223A | Transdermal formulations, methods and devices | Human Necessities | 24 | Expired |
| US5512292A | Transdermal contraceptive formulations methods and devices | Human Necessities | 20 | Expired |
| US5320850A | Transdermal delivery of the gestogen ST-1435 and devices therefor | Human Necessities | 10 | Expired |
| US6174545A | Drug delivery devices and process of manufacture | Human Necessities | 7 | Expired |
| US6248348A | Incorporating poly-N-vinly amide in a transdermal system | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.